DrugPatentWatch Database Preview
Emmaus Medcl Company Profile
What is the competitive landscape for EMMAUS MEDCL, and what generic and branded alternatives to EMMAUS MEDCL drugs are available?
EMMAUS MEDCL has two approved drugs.
Summary for Emmaus Medcl
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Emmaus Medcl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emmaus Medcl | ENDARI | l-glutamine | FOR SOLUTION;ORAL | 208587-001 | Jul 7, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Emmaus Medcl | ENDARI | l-glutamine | FOR SOLUTION;ORAL | 208587-001 | Jul 7, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Emmaus Medcl | NUTRESTORE | l-glutamine | FOR SOLUTION;ORAL | 021667-001 | Jun 10, 2004 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Emmaus Medcl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Emmaus Medcl | NUTRESTORE | l-glutamine | FOR SOLUTION;ORAL | 021667-001 | Jun 10, 2004 | 5,288,703 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
